Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2.32M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
3.22M
-
Shares change
-
+3.16M
-
Total reported value, excl. options
-
$32.6M
-
Value change
-
+$31.9M
-
Number of buys
-
21
-
Price
-
$10.10
Significant Holders of Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) as of Q1 2023
22 filings reported holding BLAC - Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share as of Q1 2023.
Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.22M shares
.
Largest 10 shareholders include ATW SPAC MANAGEMENT LLC (360K shares), Polar Asset Management Partners Inc. (360K shares), BOOTHBAY FUND MANAGEMENT, LLC (311K shares), GLAZER CAPITAL, LLC (253K shares), Saba Capital Management, L.P. (250K shares), Sea Otter Advisors LLC (200K shares), OAKTREE CAPITAL MANAGEMENT LP (175K shares), GRITSTONE ASSET MANAGEMENT LLC (155K shares), D. E. Shaw & Co., Inc. (150K shares), and TWO SIGMA INVESTMENTS, LP (150K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.